
CICC Remains a Buy on Yonghe Medical Group Co., Ltd. (2279)

I'm LongbridgeAI, I can summarize articles.
In a report released yesterday, from CICC maintained a Buy rating on Yonghe Medical Group Co., Ltd., with a price target of HK$2.46.End of Quarter Sale - 50% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Yonghe Medical Group Co., Ltd. has an analyst consensus of Moderate Buy, with a price target consensus of HK$2.46.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

